-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy_research-protocol.pdf
September 14, 2016 - c) Modulation of immune system: capability of AIT to modify the immunologic pathways that
are responsible … (MeSH)
b) All other immunologic parameters, such as T-Lymphocytes (Lymphocytes responsible for
cell-mediated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
April 01, 2013 - The responses to comments in this disposition report are
those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
January 01, 2011 - Utilization and cost of anticancer biologic products
among Medicare beneficiaries, 2006-2009
Data Points #6Anticancer Biologics
From 2006 to 2009, over 800,000
Medicare fee-for-service
beneficiaries continuously
enrolled in Parts A and B had a
claim for an anticancer biologic
of interest.
Bevacizumab was the m…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_presentation-2013.pdf
January 01, 2013 - Community Forum: Introduction to Online Tools To Support Public Deliberation
This presentation introduces online tools that can be used to support public deliberation.
During this presentation, we discuss the types of online tools that can be used to support
public deliberation and what to consider when select…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-sepsis.pdf
July 01, 2023 - The authors of this report are
responsible for its content.
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
October 30, 2012 - 71
Abstract
This chapter provides an overview of considerations for the development of outcome measures
for observational comparative effectiveness research (CER) studies, describes implications of the
proposed outcomes for study design, and enumerates issues of bias that may arise in incorporating the
ascertainme…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease-future_research.pdf
July 01, 2016 - The findings and conclusions in this
document are those of the author(s), who are responsible for its
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
December 16, 2014 - The responses to comments in this disposition report are
those of the authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
November 30, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: November 30, 2011 1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Treatment for Hepatitis C in Adults
I. Background and Obj…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
March 01, 2014 - As a
consequence, chronic cough is responsible
for up to 38 percent of pulmonary
outpatient visits
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary_0_0.pdf
April 01, 2020 - Treatment of Depression in Children and Adolescents: A Systematic Review - Evidence Summary
Purpose of Review
The purpose of the review is to examine the benefits
and harms of pharmacological and nonpharmacological
treatments for child and adolescent depressive disorders.
Key Messages
• Cognitive behavioral t…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
September 01, 2011 - The responses to comments in this disposition report
are those of the authors, who are responsible
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-protocol.pdf
January 01, 2024 - The authors of this report are
responsible for its content.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
January 01, 2017 - Treatments for Schizophrenia in Adults: A Systematic
Comparative Effectiveness Review
Number 198
Treatments for Schizophrenia in Adults: A Systematic
Review
Evidence Summary
Condition and Treatment
Strategies
Schizophrenia is a chronic mental health
condition that most often presents in
early adulthood and ca…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
January 07, 2016 - The responses to comments in this disposition report are those of the
authors, who are responsible for
-
effectivehealthcare.ahrq.gov/sites/default/files/delilberative-methods-design-carman.pdf
June 01, 2012 - Slide 30
Deliberative Methods Experiment
Agency for Healthcare Research and Quality
Community Forum
Slide 31
Background & objectives of experiment
Background
o Started in August 2010
o Literature review, Technical Expert Panel, formative research to inform
approach
Objectives
o Expand the …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
March 10, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: March 10, 2010
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Comparative Effectiveness of Medications to Reduce Risk of
Primary B…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
September 01, 2011 - The findings and conclusions
in this document are those of the author(s), who are responsible for its … that the program reports can be narrowly
technical, and, therefore, frequently not relevant to those responsible
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-proof_research.pdf
June 01, 2010 - The findings and conclusions in this document are those of the authors, who are
responsible for its … The sites were responsible for opening ports 139 and 445 to allow files to pass
through the internal
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
January 01, 2012 - The findings and
conclusions in this document are those of the authors, who are responsible for its … phase 3 registration
program for VX-770, an oral CFTR potentiator
targeting the defective protein responsible